FOB Price
Obtener el precio más reciente( Negotiable )
|Minimum Order
Place of Origin:
-
Price for Minimum Order:
-
Minimum Order Quantity:
100 Box
Packaging Detail:
we can pack the way you want
Delivery Time:
FOB Korea
Supplying Ability:
1000 Box per Month
Payment Type:
T/T, Western Union, PayPal
South Korea
Persona de contacto Ms. Jon
Dukso-ro, Namyangju-Si, Gyunggi-Do
Product Description
"A Dermal Filler Made by No.1
Hospital Group in Korea"
HyaFilia has been studied and made by CHA Hospital Group based on
its expert technology and plenty of experiences in women\'s medical
and anti-aging field. CHA group has developed a hyaluronic acid
dermal filler called Hya Filia to fulfill the expectation of Korean
aesthetic market.
Product Feature
1. Hyaluronic Acid is made of safe and natural (non-animal) skin
tissue components.
2. Product proven to be safe and its efficacy through clinical
trials from "CHA Hospital" and other major hospitals in
Korea.
3. The components are naturally biodegraded slowly from the body
which makes it the safest injection possible.
4. Clinical results proved its high durability compared to other
products in the market.
5.Competitive
Price
6. Less pain and no bruising with the use of TW
syringe.
Product Specification/Models
*HyaFilia DETAIL INFORMATION*
Ingredient : Hyaluronic acid (HA) cross-linked with BDDE
Feature : Colorless and transparent gel
Content : 1ml prefilled syringe
Storage : Store at room temperature (***0 degree), Shade the
light
Expiry date : *4months due to manufacture
Applicable areas : Forehead Lines (Worry Lines), Glabellar Lines
(Frown Lines), Nasolabial Folds, Periorbital Lines, Oral
Commissures, Acene Scar
Other Information
There are two types of Crosslinking
*BDDE (Butanediol Diglycidyl Ether)
*DVS (Divinyl Sulfone)
=> Juvederm and Restylane uses BDDE.
"Clinical demonstration data about parioral line
improvement
with Hyafilia and R product"
=> Results
Test results with a mouse proved Hyafilia\'s ingredients have
longer lasting results than J product and equivalent consistency
and validity results with R product.
The newly developed Hyafilia with
Hyaluronic Acid component was proved
its "non-inferiority" compared to R product and J
product.